Key facts
- This page summarizes Kyle Michael Wool's Form 4 filing for AIkido Pharma Inc. (DOMH).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 20 Dec 2022, 16:26.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Purchase
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
Of the 261,792 shares reported as beneficially owned directly, 179,568 shares are beneficially owned directly by Mr. Wool and 82,224 shares are beneficially owned directly by Ms. Yu. Due to an administrative error, Mr. Wool's direct ownership, as previously reported, did not reflect the 1-for-17 reverse split of the Company's common stock effective June 7, 2022. As a result, Mr. Wool's direct beneficial ownership was overstated by 23,530 shares of common stock. The amount of Mr. Wool's direct beneficial ownership has been corrected in this Form 4.
Footnote F2
Mr. Wool is the sole member of Catatonk Creek, LLC and Tioga 22, LLC.
Footnote F3
Mr. Wool controls this UTMA account until Ms. Cottone is 18 years old.
Footnote F4
Ms. Yu is the sole member of Dongam, LLC.